Article Details
Retrieved on: 2018-03-07 00:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Swiss pharma giant Roche (ROG:SIX) was responsible for the month's biggest buy - the $1.9 billion acquisition of health tech start-up <b>Flatiron Health</b> that will interest observers of collaborations between drugmakers and artificial intelligence companies. There were also deals involving Japanese pharma ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here